logo apx for dark background

October 2022

Speaker at Samsung Global Research Symposium

SEOUL 25-27 OCTOBER 2022. The Samsung Global Research Symposium on "Advanced Bioimaging: New Discovery in Life Sciences" is held by the Samsung Science and Technology Foundation, which was founded by Samsung Electronics in 2013, and is the first and largest private funding organization for basic research in Korea. It supports pioneering projects that attempt to define new problems or to solve highly challenging problems 

so that the fundamental knowledge gained may lead to technological innovations for the future world.

At the symposium, Lucas presents his group's pioneering work on how signaling activities and their responses to drugs can be accurately predicted in single cells using multi-scale multiplex imaging and machine learning.

Event website: http://samsungstf-grs.science

0C7A4865
Posted in R&D

Speaker at the Allen Institute for Cell Science

SEATTLE 17-20 October 2022. The Allen Institute for Cell Science hosts the seventh annual CytoData meeting. Established in 2016, the annual CytoData meeting brings together experts from across the world to address the challenges in cell imaging and analysis. This year’s theme was “Data analysis and deep learning strategies for image-based profiling in cell biology.” Quantitative image analysis is an emerging field that is developing at a rapid pace, and new tools and methods can help accelerate the analysis, yet democratization and standardization is needed to keep at pace. We aim to feature new tools, applications of tools, and new discoveries to bring the image-based profiling community together.

At the meeting, Lucas presents their recent breakthrough study published in Science on how the responses of individual cells to drugs can be accurately predicted in single cells using multi-scale multiplex imaging and machine learning.

Event website: https://alleninstitute.org/what-we-do/cell-science/events-training/cytodata-symposium-2022/

Posted in R&D

Options agreement with UZH

ZURICH 04 October 2022: Apricot Therapeutics AG signed an options agreement with the University of Zurich to evaluate patents rights for two patent applications based on research from the group of Lucas Pelkmans.

Posted in IP